Alvotech USA, INC.
Biopharmaceutical co. focused on the development & manufacturing of biosimilar medicines
Based in VA
🤖
AI Overview
With $120K in lobbying spend across 6 quarterly filings, Alvotech USA, INC is an active lobbying client. They deploy 19 individual lobbyists Their lobbying covers 2 issue areas. Active from 2021 to 2022.
$120K
Total Spend
2
Years Active
1
Firms Hired
19
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $120K |
| 2022 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Copyright/Patent, Health Issues
- •Issues involving patents and prescription drugs, issues involving biosimilar drugs.
- •Monitoring efforts involving patents and prescription drugs.
- •Monitoring efforts involving patents and prescription drugs.
- •Promoting access to biosimilars.
Related Analysis
Related Investigations
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.